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Abstract
Background: Snakes of the genus Bothrops, popularly known as pit vipers, are responsible for most cases of
snakebite in Brazil. Within this genus, Bothrops jararacussu and B. jararaca deserve special attention due to the
severity of their bites and for inhabiting densely populated areas. Regarding the treatment of snakebites by
Bothrops jararacussu, questions have been raised about the effectiveness of the specific bothropic antivenom in
neutralizing myotoxic effects; however, there are no accurate data for humans. Thus, the development of a
differential diagnostic kit for this species would be of great interest because it provides, for healthcare professionals,
a tool that would allow us to determine whether the accident was caused by B. jararacussu or other species of the
genus. It would also make it possible to evaluate the specificity of the treatment and to provide data for
epidemiological studies.
Methods: First, we produced a species-specific polyclonal antibody – a potential biomarker of Bothrops jararacussu
venom – against bothropstoxin-I (BthTx-I), which is also found in smaller quantities in the venoms of B. jararaca
from southern Brazil.
Results: Polyclonal antibodies against bothropstoxin-I could be separated into several species-specific
immunoglobulins. Then, aiming to develop a system of safe and standardized immunoassay, we produced
monoclonal antibodies. Seven hybridomas were obtained. Five of them were specific to the venom of B.
jararacussu and two recognized the venom of B. jararaca from the southeastern population. The use of monoclonal
antibodies also made it possible to differentiate B. jararacussu from B. jararaca venom obtained from the southern
population. Analyzing the reactivity of monoclonal antibodies against other bothropic venoms, we found mAb Bt-3
to be more specific than others for B. jararacussu venom.
Conclusions: These results show the potential of BthTx-I for producing monoclonal antibodies that differentiate
between B. jararacussu and other Bothrops species venoms.
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Background
Among the snake species of the genus Bothrops, Bothrops
jararacussu is remarkable for the low immunogenicity of
its venom, which is highly myotoxic, leading to necrosis of
striated muscle fibers and slowing tissue regeneration [1,
2]. In all Brazilian states where B. jararacussu is present,
B. jararaca is also found [3]. This makes it difficult to
differentiate between these two snakes when an accident
occurs, due to extensive homology among envenomation
symptoms [4, 5]. In Rio de Janeiro, both species have
clinical importance. In the envenomation context, the
question of the efficiency of specific bothropic antivenom
against B. jararacussu bites is often discussed, since the
myotoxic effects observed in mice are not completely neu-
tralized. For this reason, some researchers have suggested
the use of a combinated bothropic-crotalic antivenom as a
more appropriate treatment [1, 6–10].
The proteomic characterization of B. jararacussu venom
and the immunoreactivity of anti-B. jararaca and anti-B.
jararacussu sera have contributed to our understanding of
some of the immunochemical characteristics of B. jarara-
cussu venom and led to a suggestion for the use of
bothropstoxin-I (BthTx-I) as a biomarker molecule [11].
This molecule is a phospholipase A2 Lys-49 (Lys-49
PLA2) from B. jararacussu venom with three α-helices
and two antiparallel β-sheets [12, 13]. This protein is the
most abundant myotoxin that can be isolated from B. jar-
aracussu venom and although it exhibits severe neurotox-
icity and myotoxicity, it shows little or no phospholipase
activity [13, 14]. This toxin is able to promote injury in
lipid bilayer of cell membranes through a calcium-
independent mechanism, inducing myonecrosis [13, 15].
Lys49-PLA2 molecules have been described in various
Bothrops venoms, such as BnSP-7 from B. neuwiedi, myo-
toxin I from B. moojeni, and BaTX from B. alternatus,
among others [16–18]. Recently, Gonçalves-Machado et
al. [19] described the presence of BthTx-I in venoms of B.
jararaca from the southern region of Brazil. Methods for
differentiating the envenomation caused by B. jararacussu
from the one caused by B. jararaca are very important in
order to enable the epidemiological study of accidents
with these two snakes, as well as to allow studies of treat-
ment efficiency for B. jararacussu bites in humans. In this
context, the objective of the present study was to produce
monoclonal antibodies from BthTx-I to be used as tools
for the development of a differential diagnostic kit for
bites provoked by B. jararacussu.
Methods
Animals and venoms
BALB/c mice (18–20 g) were provided by the Butantan
Institute. All procedures were approved by the Ethics
Committee for Animal Research of Butantan Institute
(process no. 697/10). The venoms of Bothrops
alternatus, B. atrox, B. diporus, B. erytromelas, B. fonse-
cai, B. insularis, B. jararaca, B. jararacussu, B.leucurus,
B. moojeni, B. neuwiedi and B. pubescens were provided
by the Laboratory of Herpetology of the Vital Brazil
Institute.
Isolation of bothropstoxin-I
Bothropstoxin-I was isolated following the description of
Correa-Netto et al. [11]. Briefly, B. jararacussu venom
(500 mg) dissolved in 5 mL buffer (20 mM Tris-HCl,
150 mM NaCl, pH 8.8) was applied onto a Sephacryl S-
200 HR column (2.6 × 100 cm) with a flow rate of
17 mL/h generating four distinct peaks. The third peak,
which contained proteins with a maximal apparent mo-
lecular mass of 30 kDa, was dialyzed against PBS buffer
(50 mM sodium phosphate/150 mM sodium chloride,
pH 7.4) and applied to an ion-exchange column (Mono
S HR 5/5, Pharmacia) at a flow rate of 1.0 mL/min.
Elution using a linear gradient of 0–1 M NaCl in the
same phosphate buffer yielded two peaks; the second
was identified as BthTx-I by mass spectrometry. The elu-
tion profile was monitored by absorbance at 280 nm.
Polyclonal anti-BthTx-I serum produced in rabbits
Two rabbits were injected subcutaneously with 500 μg
of BthTx-I emulsified in complete Marcol/Montanide
adjuvant. After the first injection, boosters were made 2,
3, 4 and 5 weeks later with incomplete Marcol/Monta-
nide adjuvant. Blood samples were drawn after the 5th
week and the immune serum was collected.
Purification of polyclonal species-specific antibodies
Two columns of Sepharose 4B activated by cyanogen
bromide were prepared, one with Bothrops jararacussu
(jararacussu-Sepharose) and the other with Bothrops
jararaca from the southeast region of the country (jarar-
aca-Sepharose). The column preparation followed in-
structions from Amersham Biosciences. Both columns
were equilibrated with PBS buffer (50 mM sodium phos-
phate/150 mM sodium chloride, pH 7.4). Anti-BthTx-I
serum was applied to the jararacussu-Sepharose column
at a flow rate of 1 mL/min, thereafter discarding the
unbound material. Immunoglobulins with affinity for the
B. jararacussu venom were collected and applied to the
jararaca-Sepharose column at a flow rate of 1 mL/min.
The immunoglobulins that did not bind to the column
were collected and those with affinity for the venom of
B. jararaca were discarded. The pool of IgGs that did
not bind to the column was designated “purified species-
specific anti-BthTx-I”. For the elution of immunoglobu-
lins from both columns, 0.2 M glycine/HCl buffer,
0.15 M NaCl, pH 2.8 was used. The elution was moni-
tored by absorbance at 280 nm.
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Immunization of mice
Mice (female Balb/c) were immunized according to
Fernandes et al. [20]. Four days after the last booster, an-
imals were bled from the ophthalmic plexus and one
animal immunized with BthTx-I was killed and popliteal
lymph nodes were removed.
Production and purification of monoclonal antibodies
(mAbs)
Monoclonal antibodies were produced as described by
Köhler and Milstein [21], with modifications. Popliteal
lymph node cells from BALB/c mice immunized with
BthTx-I were fused with SP2-O cells (2:1) using polyethyl-
ene glycol 4000 (Merck). Hybrids were selected in RPMI
1640 medium containing 3% HAT (hypoxanthine 10 mM,
aminopterin 40 mM and thymidine 1.6 mM; Gibco-BRL)
and 10% FCS (Gibco-BRL) at 37 °C and 5% CO2. Super-
natant fluids were screened for species-specific antibodies
by ELISA, as described in the next section. Antibody-
secreting cells were expanded and cloned twice at limiting
dilution. The mAbs contained in culture supernatants
were purified by affinity chromatography on protein-A
Sepharose (Pharmacia) equilibrated in borate saline buffer,
pH 8.5. The proteins were eluted in 0.2 M glycine/HCl
buffer, 0.15 M NaCl, pH 2.8, and dialyzed in borate saline
buffer. An isotyping kit (Sigma) was used to determine the
heavy-chain isotype.
ELISA
ELISA was carried out according to Theakston et al.
[22]. Briefly, wells were coated with venom (1 μg/well)
or BthTx-I and, after blocking with 3% bovine serum al-
bumin, various dilutions of mAbs were added to a final
volume of 100 μL. Antigen–antibody reaction was
detected by addition of anti-mouse IgG-peroxidase con-
jugate and ortho-phenylenediamine (1 mg/mL, Sigma)
and H2O2 as enzyme substrates.
Dot blot
Dot blot was carried out as described by Towbin et al.
[23], with modifications. Briefly, samples (1 μg/μL) were
applied directly to nitrocellulose membranes. After
blocking with 3% bovine serum albumin, dilutions of
mAbs were added. Antigen–antibody reaction was
detected by addition of anti-mouse IgG-peroxidase con-
jugate and the reaction with a chromogenic substrate, 4-
chloro-1-naphthol 0.05% in 15% methanol in the
presence of 0.03% H2O2.
Results
Polyclonal species-specific antibodies
We first tested whether the anti-BthTx-I polyclonal anti-
bodies could give specific antibodies to recognize
venoms from B. jararacussu and B. jararaca. For this
purpose, we produced polyclonal antibodies in rabbits
and tested against purified BthTx-I, B. jararacussu and
B. jararaca (southeastern) venoms. As expected, the
antibodies recognized both venoms when analyzed by
ELISA and immunobloting (data not shown). With the
goal of eliminating cross-reactive IgGs from polyclonal
serum, these antibodies were subjected to affinity chro-
matography as described in Methods section, which
yielded specific IgGs called here species-specific anti-
BthTx-I. This set of antibodies clearly recognized B. jar-
aracussu venom regardless of whether they were
analyzed against individual or pooled venoms or against
purified BthTx-I (Fig. 1) and did not recognize B. jarar-
aca venom. These data clearly showed the utility of
BthTx-I in generating such specific antibodies.
Production and characterization of monoclonal antibodies
(mAbs)
Since polyclonal antibodies produced against BthTx-I were
able to differentiate between the venom of two species, we
decided to produce monoclonal antibodies. Fusion of mye-
loma SP2-O cells with popliteal lymphocytes of mice im-
munized with BthTx-I resulted in 354 hybridomas of which
21 secreted antibodies against BthTx-I. For cloning, we se-
lected 12 hybridomas, tested by ELISA, that produced the
highest optical density (>1.0) of antibodies; these were
recloned to ensure monoclonality. Seven stable, immortal-
ized clones secreting anti-BthTx-I antibodies were obtained.
These mAbs were designated Bt-1, Bt-2, Bt-3, Bt-6, Bt-10,
Bt-11 and Bt-12. All were mAbs belonging to the IgG1 iso-
type except mAb Bt-6, which belongs to the IgG2b isotype.
The mAbs were analyzed by ELISA regarding their ability
to recognize venoms from B. jararacussu and southeastern
B. jararaca. The mAbs Bt-1, Bt-2, Bt-3, Bt-6 and Bt-10
showed specific reactivity for B. jararacussu venom while
Bt-11 and Bt-12 could recognize both venoms (Fig. 2).
Since ontogenetic and individual variations are de-
scribed in Bothrops venoms we analyzed the specifi-
city with which mAbs could recognize individual
venoms of ten neonates and adults of B. jararacussu
and southeastern B. jararaca. The mAbs Bt-1, Bt-2,
Bt-3, Bt-6 and Bt-10 were specific for neonates and
adults of B. jararacussu but did not recognize the
venoms of southeastern B. jararaca (Fig. 3a). On the
other hand, mAbs Bt-11 and Bt-12 recognized both
venoms (B. jararacussu and B. jararaca) independ-
ently of the age (Fig. 3b).
Analyzing the reactivity of mAbs against the venom of B.
jararaca from the south of Brazil
As soon as we discovered the presence of BthTx-I in
the venom of B. jararaca from the south region of
Brazil, we evaluated its reactivity to mAbs using
ELISA [15]. First, a serial dilution of mAbs in PBS
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was added. With a high mAbs concentration, venom
of southern B. jararaca could be detected. However,
as the mAbs concentration decreased, the intensity of
the signal was gradually reduced until complete abro-
gation at 0.62 ng/μL. This result was reproduced with
mAb Bt-1, Bt-2, Bt-3, Bt-6 and Bt-10. Hence, Bt-11
and Bt-12 do not lose reactivity to venom of southern
B. jararaca, as expected. Figure 4 shows an example
of the results obtained using Bt-3 and Bt 11.
To confirm these data, a dot-blot analysis was car-
ried out in order to compare effects of different
mAbs and dilutions against venom from B. jarara-
cussu and southern B. jararaca. It was again demon-
strated that by using 62 nanograms of mAbs it is
possible to detect venom from B. jararacussu, but not
the one of B. jararaca from the south. At that con-
centration, only Bt-11 and Bt-12 were able to detect
BthTx-I in both B. jararacussu and B. jararaca venom
from the south (Fig. 5).
Cross-reactivity with venoms from different species
We investigated whether these mAbs would recognize
venoms of other Bothrops species from Brazil. The mAbs
Bt-1, Bt-2, Bt-6, Bt-10, Bt-11 and Bt-12 showed cross-
reactivity with the venom of B. leucurus, B. moojeni, B.
neuwiedi and B. pubescens. However, Bt-3 was highly
specific to the venom of B. jararacussu, not recognizing
any other Brazilian Bothrops venom (Table 1). The mAbs
Bt-10 and Bt-11 showed cross-reactivity with the
venoms of B. diporus and B. atrox (Table 1). Dot blot
confirmed the results obtained by ELISA (not shown).
Monoclonal 3 (Bt-3) showed the highest specificity for
B. jararacussu venom, highlighting the potential for this
antibody as a tool for identifying accidents by B. jarara-
cussu in some Brazilian states.
Discussion
The use of immunodiagnostic tests that allow for the
elucidation of the pattern of envenomation caused by
Fig. 1 Species-specific recognition of anti-BthTx-I against B. jararacussu and B. jararaca venom. The purified antibodies were tested against (a) pools,
individual venoms of (b) B. jararacussu and (c) southeastern B. jararaca of different ages (neonate and adults) through dot blot. One microgram of each
venom was applied to a nitrocellulose membrane and subjected to recognition by the polyclonal species-specific antibodies at a dilution of 1:1000
Fig. 2 Analysis of mAb recognition of Bothrops venoms. ELISA plates were sensitized with crude venom of (a) B. jararacussu or (b) southeastern B.
jararaca, and then tested with mAbs. The test was performed in triplicate and serum polyclonal anti-BthTx-I produced in mice was used as positive
control. Normal serum and supernatant of SP2-O cells provided negative controls
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venomous animals is recommended by the World
Health Organization. This emphasizes the need to im-
prove the quality of epidemiological and clinical data on
accidents caused by venomous animals, in order to im-
prove the therapeutic approach [24]. Nevertheless, com-
mon antigens present in venoms from different snake
species have shown to be a major problem in developing
immunodiagnostic tests [25–27].
In this study, we produced polyclonal antibodies in rab-
bits against BthTx-I with the aim of differentiating be-
tween venoms from B. jararacussu and B. jararaca,
snakes of medical importance for the southeastern region
of Brazil, especially the state of Rio de Janeiro. The pro-
duced antibodies showed extensive cross-reactivity with B.
jararaca venom when tested by different immunological
methods (data not shown). Then, the cross-reacting mole-
cules were removed by affinity chromatography (Fig. 1).
Other authors have successfully used a similar approach
to differentiate among the snake venoms from Bothrops,
Lachesis, Crotalus and Micrurus due to their overlapping
distribution in Brazil [28–31]. However, polyclonal anti-
bodies resulting from immunization of animals vary in
different matches, given the variability of animal and
immunization protocols [32].
In contrast, the monoclonal antibody constitutes a valu-
able tool to develop methods for the identification of un-
known antigens contained within a mixture of antigens,
since each hybridoma is specific for a single antigenic de-
terminant. Because of their high specificity, monoclonal
antibodies are standardized reagents that can accurately
point out differences in the same or in different molecules,
making them important tools in the basic research, immu-
nodiagnosis and clinical studies [33]. Nakamura et al. [34]
purified a toxin from Trimeresurus flavoviridis venom
(habutobin) and produced monoclonal antibodies that de-
tect habutobin levels in plasma of different animals. Later,
Malli and et al. [35] produced monoclonal antibodies
against purified toxins from the venom of the spider
Cupiennius salei and used it to detect venom in enveno-
mated patients. Such antibodies contributed to an increase
in technical specificity of antibodies as immunodiagnostic
tools and made it possible to discover the identity of the
offending animal [35].
In our study, we showed that monoclonal antibodies
raised against BthTx-I are capable of distinguishing be-
tween B. jararacussu and B. jararaca venoms from differ-
ent regions, as well as other Bothropic venoms (Table 1).
In Brazil, there is no commercial kit available for snake
venom detection. Only Australia produces a detection kit,
which is based on polyclonal antibodies [36–40]. In this
context, the relevance of our work is to generate tools for
implementation of a detection kit focused on identifying
the offending animal when two species or subspecies of
clinical relevance are suspected.
The variability in the composition and activities of
snake venoms is reported in several studies and can be
seen at various levels including ontogenetic, geographic,
sexual, inter and intra-specific [41–44]. In this context,
ontogenetic changes in venoms are found in most stud-
ies that deal with variability [45, 46]. Tan et al. [47]
Fig. 3 Analysis of mAbs against neonates and adult individual venoms. In (a) individual venom of B. jararacussu and (b) individual venom of
southeastern B. jararaca. One microgram of each venom was applied to a nitrocellulose membrane and incubated with mAbs, followed by anti-mouse
IgG-peroxidase. The antigen-antibody reaction was developed. Given the reproducibility of the mAbs against ten individual venoms (neonates and
adults) of B. jararacussu and B. jararaca, in this study we show representative results using the venom of one neonate and one adult of each snake
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found qualitative differences in protein profiles of neo-
nates and adults of Notechis scutatus venoms. Furtado et
al. [48], analyzing the actions of venoms from nine spe-
cies of Bothrops snakes, found significant ontogenetic
changes in lethal, enzymatic and the blood clotting activ-
ities. Our results show that individual B. jararacussu
venoms were recognized by monoclonal antibodies, both
from adults and neonates. These results show that
BthTx-I is present in the venom of B. jararacussu of dif-
ferent ages (Fig. 3). It is also important to note that
Lys49-PLA2 is a conserved toxin present in venoms of
many species of Bothrops snakes. Thus, a monoclonal
Fig. 4 Titration of monoclonal antibodies. A 96-well plate was sensitized overnight with one microgram of BthTx-I and venoms from B. jararacussu,
southeastern B. jararaca and southern B. jararaca. The plate was then incubated with various concentrations of mAb and revealed with anti-mouse IgG
labeled with peroxidase. The arrow in (a) shows the concentration of mAb Bt-3 (0.62 ng/μL) which recognizes BthTx-I and B. jararacussu venom. The
venoms from B. jararaca from the south and southeast were not recognized. In (b), titration of mAb Bt-12. Given the reproducibility of the mAbs against
BthTx-I, B. jararacussu, southeastern B. jararaca and southern B. jararaca venoms, only a representative result is showed for mAb Bt-3 (representing results
from Bt-1, Bt-2, Bt-6 and Bt-10) and for mAb Bt-12 (representing results from Bt-11)
Fig. 5 Analysis of mAbs against B. jararacussu and B. jararaca (south) venoms. One microgram of B. jararacussu or southern B. jararaca venom was applied
directly to a nitrocellulose membrane. After blocking, 1000 or 62 nanograms of mAbs was applied. In (a) and (b) mAbs against B. jararacussu venom and
(c) and (d) mAbs against southern B. jararaca venom. Given the reproducibility of the mAbs against the B. jararacussu and southern B. jararaca venoms,
only a representative result for mAb Bt-3 (results from Bt-1, Bt-2, Bt-6 and Bt-10) and another for mAb Bt-12 (results from Bt-11) are showed
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antibody that recognizes BthTx-I may recognize the
homologous molecules in other venoms, explaining our
data in the ELISA assay (Table 1).
A similar profile of recognition can be observed when
comparing our monoclonal antibodies with those de-
scribed by Prado et al. [49]. The camelid antibody frag-
ments (VHH) with specificity for BthTx-I and BthTx-II
from B. jararacussu venom were selected from an
immune VHH phage display library. Corroborating our
results, some clones showed reactivity against venoms
from B. moojeni, B. leucurus and B. diporus and did not
recognize B. alternatus venom [49]. This last venom con-
tains a protein with 90% homology with BthTX-I, called
BaTX. Ponce-Soto et al. [18] isolated and characterized
BaTX that constitutes approximately 5% of the crude
venom. We suggest that this low level of BaTX in B.
alternatus venom is the cause of the lack of recognition.
In this context, BthTx-I from the southern B. jararaca
venom shows 100% homology with BthTx-I from B. jar-
aracussu venom, and it represents 13.8% of the proteins
in southern B. jararaca venom [19]. This could be an
obstacle to spreading the use of monoclonal antibodies
developed by our group to differentiate among B. jarar-
aca bites. However, the BthTx-I from B. jararacussu
venom represents approximately 40% of total proteins,
the highest concentration described so far for Bothrops
venoms [12, 13]. This difference in BthTx-I concentra-
tion between the two Bothrops species may influence the
signal generated by mAbs in ELISA. For this reason, the
dilution of antibodies preserves only B. jararacussu
venom detection, since it is the venom with the higher
level of BthTx-I among all Bothrops species (Figs. 4
and 5). Furthermore, accidents caused by B. jarara-
cussu and B. jararaca are epidemiologically relevant
in Rio de Janeiro State [3], where B. jararaca do not pro-
duce BThx-I. Thus, the use of a diagnostic kit from a
mAb may be regionally important. A diagnostic kit able to
discriminate between B. jararaca and B. jararacussu
venoms would solve, in Rio de Janeiro, questions related
to epidemiology and treatment of patients.
There is a growing interest in the standardization of the
ELISA technique in the form of an immunodiagnostic
Table 1 Cross-reactivity with Brazilian Bothrops venoms by ELISA
Bt-1 Bt-2 Bt-3 Bt-6 Bt-10 Bt-11 Bt-12 Anti-BthTx-I NS
Bothrops alternatus – – – – – – – – –
(0.134) (0.110) (0.136) (0.112) (0.103) (0.141) (0.118) (0.151) (0.102)
Bothrops atrox – – – – **** **** – **** –
(0.221) (0.119) (0.117) (0.134) (2.100) (2.201) (0.313) (2.231) (0.110)
Bothrops diporus – – – – – **** – **** –
(0.208) (0.147) (0.109) (0.217) (0.214) (2,314) (0.219) (2.403) (0.108)
Bothrops erytromelas – – – – – – – – –
(0.144) (0.152) (0.201) (0.141) (0.226) (0.352) (0.324) (0.150) (0.104)
Bothrops fonsecai – – – – – – – – –
(0.187) (0.138) (0.184) (0.209) (0.213) (0.247) (0.298) (0.162) (0.103)
Bothrops insularis – – – – – – – – –
(0.201) (0.192) (0.199) (0.229) (0.114) (0.232) (0.288) (0.142) (0.111)
Bothrops jararaca
(southeast)
– – – – – **** **** **** –
(0.234) (0.103) (0.148) (0.136) (0.132) (2.503) (2.603) (2.633) (0.131)
Bothrops jararacussu **** **** **** **** **** **** **** **** –
(2.657) (2.421) (2.303) (2.529) (2.437) (2.509) (2.619) (2.628) (0.122)
Bothrops leucurus **** ** – **** **** **** – **** –
(1.407) (0.634) (0.132) (1.914) (2.098) (2.001) (0.215) (2.383) (0.134)
Bothrops moojeni **** ** – **** **** **** **** **** –
(1.543) (0.899) (0.131) (2.008) (2.103) (2.125) (2.244) (2.479) (0.143)
Bothrops neuwiedi **** ** – **** **** **** – **** –
(1.722) (0.987) (0.124) (2.103) (2.103) (2.136) (0.200) (2.501) (0.127)
Bothrops pubescens **** ** – **** **** **** – **** –
(1.481) (0.923) (0.116) (2.002) (2.103) (2.212) (0.235) (2.426) (0.149)
Polyclonal anti-BthTx-I serum and normal serum (NS) of mice were utilized
**** Strong binding (optical density > 1.0); ** medium binding (optical density between 0.5 and 1.0); − weak or no binding (optical density between 0.1 and 0.5)
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test, as used in Australia. It could be used in different lo-
cations and could offer to healthcare professionals a quick
diagnosis of the genus involved in the accident and the
amount of injected venom. Moreover, it is noteworthy that
the data on snakebite are quite fragmentary because of the
lack of information and recorded data. Therefore, the de-
velopment of a regional diagnostic kit for identification of
snake venoms could improve the treatment of snakebite
victims and contribute to epidemiological studies.
Conclusion
Our results demonstrate the potential of BthTx-I as a
biomarker molecule to be used for antibody production
(monoclonal and polyclonal) and posterior specific de-
tection of B. jararacussu venom. These antibodies may
be an important tool for the development of a detection
kit that differentiates between venoms from B. jarara-
cussu and B. jararaca, especially in Rio de Janeiro where
both species are epidemiologically relevant.
Abbreviations
BthTx-I: Bothropstoxin-I; mAbs: monoclonal antibodies
Acknowledgments
The authors would like to thank Ana Lúcia de Oliveira Carvalho and Dione
Maria da Silva for their technical assistance and Dr. Martha Sorenson for
English review. Thanks are also due to the Center for the Study of Venoms
and Venomous Animals (CEVAP) of UNESP for enabling the publication of
this paper (Edital Toxinologia CAPES no. 063/2010, Process no.
230.38.006285/2011-21, AUXPE Toxinologia 1219/2011).
Funding
The present work was supported by the National Council for Scientific and
Technological Development (CNPq), Rio de Janeiro Research Foundation
(FAPERJ) and by by the Edital Toxinologia CAPES no. 063/2010, Process no.
2308.006277/2011-85, AUXPE 1517/2011.
Authors’ contributions
RTA wrote the article draft, performed the data collection, analysis and
interpretetion. CCN participate in experimental design edited and revised the
article. LBM and CRFS participated in data collection and critical revision of
the article. IF supervised the experiments on monoclonal antibodies and
performed a critical revision of the article. RBZ supervised the experiments,
contributed to development of concept and experimental design, writing,
reviewing and editing the article. All authors read and approved the final
manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
All animal procedures were approved by the Ethics Committee for Animal
Research of Butantan Institute (process no. 697/10).
Author details
1Laboratório de Hemostase e Venenos, Instituto de Bioquímica Médica
Leopoldo de Meis, Universidade Federal do Rio de Janeiro (UFRJ), Rio de
Janeiro, RJ, Brasil. 2Instituto Vital Brazil, Niterói, RJ, Brasil. 3Instituto Butantan,
São Paulo, SP, Brasil.
Received: 22 September 2016 Accepted: 24 February 2017
References
1. dos Santos MC, Gonçalves LRC, Fortes-Dias CL, Cury Y, Gutiérrez JM, Furtado
MFD. A eficácia do antiveneno botrópico-crotálico na neutralização das
principais atividades do veneno de Bothrops jararacussu. Rev Inst Med Trop
São Paulo. 1992;34(2):77–83.
2. Luna KPO, da Silva MB, Pereira VRA. Clinical and immunological aspects of
envenomations by Bothrops snakes. J Venomous Anim Toxins Incl Trop Dis.
2011;17(2):130–41.
3. Melgarejo AR. Serpentes peçonhentas do Brasil. In: Cardoso JLC, França FOS,
Fan HW, Málaque CMS, Haddad Jr, editors. Animais peçonhentos no Brasil:
Biologia, clínica e terapêutica dos acidentes. São Paulo: Sarvier; 2003. p. 33–61.
4. Maruyama M, Kamiguti AS, Cardoso JLC, Sano-Martins IS, Chudzinski AM,
Santoro ML, et al. Studies on blood coagulation and fibrinolysis in patients
bitten by Bothrops jararaca (jararaca). Thromb Haemost. 1990;63(3):449–53.
5. Sanchez EF, Freitas TV, Ferreira-Alves DL, Velarde DT, Diniz MR, Cordeiro MN,
et al. Biological activities of venoms from South American snakes. Toxicon.
1992;30(1):95–103.
6. Brazil V. A defesa contra o ofidismo. São Paulo: Pocai & Weiss; 1911.
7. Dias da Silva W, Guidolin R, Raw I, Higashi HG, Morais CP, Lima JF, et al.
Cross-reactivity of horse monovalent antivenoms to venoms of ten Bothrops
species. Mem Inst Butantan. 1989;51(4):153–68.
8. Oshima-Franco Y, Leite GB, Silva GH, Cardoso DF, Hyslop S, Giglio JR, et al.
Neutralization of the pharmacological effects of bothropstoxin-I from
Bothrops jararacussu (jararacuçu) venom by crotoxin antiserum and heparin.
Toxicon. 2001;39(10):1477–85.
9. Zamunér SR, da Cruz-Höfling MA, Corrado AP, Hyslop S, Rodrigues-Simioni L.
Comparison of the neurotoxic and myotoxic effects of Brazilian Bothrops venoms
and their neutralization by commercial antivenom. Toxicon. 2004;44(3):259–71.
10. Beghini DG, da Cruz-Höfling MA, Randazzo-Moura P, Rodrigues-Simioni L,
Novello JC, Hyslop S, et al. Cross-neutralization of the neurotoxicity of
Crotalus durissus terrificus and Bothrops jararacussu venoms by antisera
against crotoxin and phospholipase A2 from Crotalus durissus cascavella
venom. Toxicon. 2005;46(6):604–11.
11. Correa-Netto C, Teixeira-Araujo R, Aguiar AS, Melgarejo AR, De-Simone SG,
Soares MR, et al. Immunome and venome of Bothrops jararacussu: a
proteomic approach to study the molecular immunology of snake toxins.
Toxicon. 2010;55(7):1222–35.
12. Kashima S, Roberto PG, Soares AM, Astolfi-Filho S, Pereira JO, Giuliati S, et al.
Analysis of Bothrops jararacussu venomous gland transcriptome focusing on
structural and functional aspects: I—gene expression profile of highly
expressed phospholipases A2. Biochimie. 2004;86(3):211–9.
13. Homsi-Brandeburgo MI, Queiroz LS, Santo-Neto H, Rodrigues-Simioni CL,
Giglio JR. Fractionation of Bothtrops jararacussu snake venom: partial
chemical characterization and biological activity of bothropstoxin. Toxicon.
1988;26(7):473–9.
14. Rodrigues-Simioni L, Borgese N, Ceccarelli B. The effects of Bothrops
jararacussu venom and its components on frog nerve-muscle preparation.
Neuroscience. 1983;10(2):475–89.
15. Lomonte B, Angulo Y, Calderón L. An overview of lysine-49 phospholipase
A2 myotoxins from crotalid snake venoms and their structural determinants
of myotoxic action. Toxicon. 2003;42(8):885–901.
16. Soares AM, Guerra-Sá R, Borja-Oliveira CR, Rodrigues VM, Rodrigues-Simioni
L, Rodrigues V, et al. Structural and functional characterization of BnSP-7, a
Lys49 myotoxic phospholipase A(2) homologue from Bothrops neuwiedi
pauloensis venom. Arch Biochem Biophys. 2000;378(2):201–9.
17. Soares AM, Andrião-Escarso SH, Angulo Y, Lomonte B, Gutiérrez JM,
Marangoni S, et al. Structural and functional characterization of myotoxin I,
a Lys49 phospholipase A(2) homologue from Bothrops moojeni (Caissaca)
snake venom. Arch Biochem Biophys. 2000;373(1):7–15.
18. Ponce-Soto LA, Lomonte B, Gutiérrez JM, Rodrigues-Simioni L, Novello JC,
Marangoni S. Structural and functional properties of BaTX, a new Lys49
phospholipase A2 homologue isolated from the venom of the snake
Bothrops alternatus. Biochim Biophys Acta. 2007;1770(4):585–93.
19. Gonçalves-Machado L, Pla D, Sanz L, Jorge RJ, Leitão-De-Araújo M, Alves ML,
et al. Combined venomics, venom gland transcriptomics, bioactivities, and
antivenomics of two Bothrops jararaca populations from geographic
isolated regions within the Brazilian Atlantic rainforest. J Proteome.
2016;135:73–89.
Araujo et al. Journal of Venomous Animals and Toxins including Tropical Diseases  (2017) 23:12 Page 8 of 9
20. Fernandes I, Assumpção GG, Silveira CR, Faquim-Mauro EL, Tanjoni I,
Carmona AK, et al. Immunochemical and biological characterization of
monoclonal antibodies against BaP1, a metalloproteinase from Bothrops
asper snake venom. Toxicon. 2010;56(6):1059–65.
21. Köhler G, Milstein C. Continuous cultures of fused cells secreting antibody
of predefined specificity. Nature. 1975;256(5517):495–7.
22. Theakston RDG, Lloyd-Jones MJ, Reid HA. Micro-ELISA for detecting and
assaying snake venom and venom antibody. Lancet. 1977;2(8039):639–41.
23. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from
polyacrylamide gels to nitrocellulose sheets: procedure and some
applications. Proc Natl Acad Sci. 1979;76(9):4350–4.
24. World Health Organization. Progress in the characterization of venoms
and standardization of antivenoms. WHO Offset Public. 1981;(58):1–44.
http://www.who.int/iris/handle/10665/37282.
25. McCarthy NJ. Snake venom detection kit. Med J Aust. 1984;140(9):518.
26. Marshall LR, Herrmann RP. Cross-reactivity of bardick snake venom with
death adder antivenom. Med J Aust. 1984;140(9):541–2.
27. Ho M, Warrell MJ, Warrell DA, Bidwell D, Voller A. A critical reappraisal of the
use of enzyme-linked immunosorbent assays in the study of snake bite.
Toxicon. 1986;24(3):211–21.
28. Heneine LG, Catty D, Theakston RDG. Development of a species-specific
ELISA for Brazilian pit-viper venoms. Braz J Med Biol Res. 1990;23(6–7):585–8.
29. Audebert F, Grosselet O, Sabouraud A, Bon C. Quantitation of venom
antigens from European vipers in human serum or urine by ELISA. J Anal
Toxicol. 1993;17(4):236–40.
30. Heneine LG, Catty D. Species-specific detection of venom antigens from
snakes of the Bothrops and Lachesis genera. Toxicon. 1993;31(5):591–603.
31. Chavez-Olortegui C, Lopes CS, Cordeiro FD, Granier C, Diniz CR. An enzyme
linked immunosorbent assay (ELISA) that discriminates between Bothrops
atrox and Lachesis muta muta venoms. Toxicon. 1993;31(4):417–25.
32. Nelson PN, Fletcher SM, MacDonald D, Goodall DM, Jefferis R. Assay
restriction profiles of three monoclonal antibodies recognizing the G3m(u)
allotype. Development of an allotype specific assay. J Immunol Methods.
1991;138(1):57–64.
33. Blottière HM, Daculsi G, Anegon I, Pouezat JA, Nelson PN, Passuti N.
Utilization of activated U937 monocytic cells as a model to evaluate
biocompatibility and biodegradation of synthetic calcium phosphate.
Biomaterials. 1995;16(6):497–503.
34. Nakamura M, Hanashiro K, Kosugi T. A modification of the ELISA-double
sandwich method for estimating the concentration of habutobin. Toxicon.
1993;31(10):1325–8.
35. Malli H, Imboden H, Kuhn-Nentwig L. Quantifying the venom dose of the spider
Cupiennius salie using monoclonal antibodies. Toxicon. 1998;36(12):1959–69.
36. Trevett AJ, Nwokolo NC, Kevau IH, Seaton RA. Cerebrovascular accident after
taipan bite. Med J Aust. 1994;160(2):94.
37. Sutherland SK, Leonard RL. Snakebite deaths in Australia 1992–1994 and a
management update. Med J Aust. 1995;163(11–12):616–8.
38. Trevett AJ, Lalloo DG, Nwokolo NC, Theakston DG, Naraqi S, Warrell DA.
Venom detection kits in the management of snakebite in Central province,
Papua New Guinea. Toxicon. 1995;33(5):703–5.
39. Mead HJ, Jelinek GA. Suspected snakebite in children: a study of 156
patients over 10 years. Med J Aust. 1996;164(8):467–70.
40. Southern DA, Callanan VI, Gordon GS. Severe envenomation by the taipan
(Oxyuranus scutellatus). Med J Aust. 1996;165(11–12):662–4.
41. Chippaux JP, Willians V, White J. Snake venoms variability: methods of study,
results and interpretation. Toxicon. 1991;29(11):1279–303.
42. Martins AM, Toyama MH, Havt A, Novello JC, Marangoni S, Fonteles MC, et
al. Determination of Crotalus durissus cascavella venom components that
induce renal toxicity in isolated rat kidneys. Toxicon. 2002;40(8):1165–71.
43. Mushinsky HR, Miller DE. Predation on Water Snakes: Ontogenetic and
Interspecific Considerations. Copeia. 1993;1993(3):660–5.
44. Andrade RO, Silvano RAM. Comportamento alimentar e dieta da “falsa coral”
Oxyrhopus guibei Hoge & Romano (Serpentes, Colubridae). Rev Bras Zool.
1996;13(1):143–50.
45. López-Lozano JL, de Sousa MV, Chávez-Olortegui C, Sanchez EF, Muniz EG,
Bührnheim PF, et al. Ontogenetic variation of metalloproteinases and
plasma coagulant activity in venoms of wild Bothrops atrox specimens from
Amazonian rain forest. Toxicon. 2002;40(7):997–1006.
46. Saldarriaga MM, Otero R, Núñez V, Toro MF, Díaz A, Gutiérrez JM.
Ontogenetic variability of Bothrops atrox and Bothrops asper snake venoms
from Colombia. Toxicon. 2003;42(4):405–11.
47. Tan NH, Ponnudurai G, Mirtschin PJ. A comparative study on the biological
properties of venoms from juvenile and adult common tiger snake
(Notechis scutatus) venoms. Comp Biochem Physiol B. 1993;106(3):651–4.
48. Furtado MF, Maruyama M, Kamiguti AS, Antonio LC. Comparative study of
nine Bothrops snake venoms from adult female snakes and their offspring.
Toxicon. 1991;29(2):219–26.
49. Prado ND, Pereira SS, da Silva MP, Morais MS, Kayano AM, Moreira-Dill LS, et
al. Inhibition of the Myotoxicity Induced by Bothrops jararacussu Venom and
Isolated Phospholipases A2 by Specific Camelid Single-Domain Antibody
Fragments. PLoS One. 2016;11(3):e0151363.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Araujo et al. Journal of Venomous Animals and Toxins including Tropical Diseases  (2017) 23:12 Page 9 of 9
